Search

everythinglearnresearchcommunity

for

Search:↓

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Finasteride use is linked to a higher risk of obstructive sleep apnea.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Microbial biosurfactants could be a safer and environmentally friendly alternative to chemical surfactants in cosmetics.

The hydrogel with Finasteride provides controlled, sustained drug release and improved bioavailability.

The 0.1% finasteride nanoparticles are efficient, uniform, and stable.

DMSO causes reversible swelling in hair but has a complex, less reversible effect on skin.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Flutamide, delivered by solid lipid nanoparticles, could potentially treat hair loss.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

The method accurately measures finasteride in bulk and dosage forms.

FFA has higher long-term remission rates than LPP.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Fisetin may help treat psoriasis and reduce skin inflammation.

Compound 6 is a promising candidate for better wound healing.

Infrared light can trigger drug release from gold nanoparticle carriers in hair follicles.

The green alga Parachlorella sp. has potential for use in cosmetics and health products due to its antioxidant, anti-hypertensive, and hair growth properties.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.